DJ Bolt Biotherapeutics Shares Jump in Trading Debut After Upsized IPO >BOLT
By Colin Kellaher
Shares of Bolt Biotherapeutics Inc. rose more than 25% in their trading debut Friday after the immuno-oncology company's upsized initial public offering was priced above already increased expectations.
Bolt shares were recently changing hands at $25.06, up 25%, after opening at $26.10.
The Redwood City, Calif., company sold 11.5 million shares at $20 apiece after previously raising the offering to 10.5 million shares at $18 to $19 each from earlier plans to sell about 8.83 million shares at between $16 and $18.
Write to Colin Kellaher at email@example.com
(END) Dow Jones Newswires
February 05, 2021 11:03 ET (16:03 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.